Federica D'Antonio

Pubblicazioni

Titolo Pubblicato in Anno
Intratumoral Switch of Molecular Phenotype and Overall Survival in Muscle Invasive Bladder Cancer CANCERS 2022
Resound Trial: A phase 2 study of regorafenib in patients with thymoma (type B2-B3) and thymic carcinoma previously treated with chemotherapy CANCER 2022
Advances in drug treatments for mesothelioma EXPERT OPINION ON PHARMACOTHERAPY 2022
Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy MINERVA UROLOGY AND NEPHROLOGY 2022
Clinical predictors of cardiac toxicity in HER2-positive early breast cancer patients treated with adjuvant s.c. versus i.v. trastuzumab BREAST 2021
Systemic treatments for thymic tumors: a narrative review MEDIASTINUM 2021
A phase II study of the combination of gemcitabine and imatinib mesylate in pemetrexed-pretreated patients with malignant pleural mesothelioma LUNG CANCER 2020
Pulmonary sarcomatoid carcinoma presenting both ALK rearrangement and PD-L1 high positivity: A case report on the therapeutic regimen 2019

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma